US 2024/0197701 A1Published application

Androgen receptor inhibition to treat sepsis and shock

AssigneesRhode Island Hospital, Applied Biology, Inc.

InventorsGerard J. Nau, Carlos G. Wambier, Andy Goren

Life of this patent

Estimating the term…

Abstract

The invention provides a method for applying diarylhydantoin compounds, including flutamide, bicalutamide, enzalutamide, apalutamide, and proxalutamide, to treat sepsis and conditions that mimic sepsis.

Claims3

Dependent claims

A method for applying diarylhydantoin compounds, including flutamide, bicalutamide, enzalutamide, apalutamide, and proxalutamide, to treat sepsis and conditions that mimic sepsis, including COVID-19 infection.

Dependencies are inferred from the claim text.

Facts

Application: 18/286,985Filed 19 Apr 2022
Priority: 19 Apr 2021
Published: 20 Jun 2024
Term ends: Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 31/4439
Containing further heterocyclic ring systems: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
A61P 17/02
Drugs for dermatological disorders: for treating wounds, ulcers, burns, scars, keloids, or the like
A61K 31/167
Having aromatic rings, e.g. colchicine, atenolol, progabide: having the nitrogen of a carboxamide group directly attached to the aromatic ring,…
A61K 31/277
Nitriles; Isonitriles: having a ring, e.g. verapamil

Family

Application63/176,488Us provisional application · filed 19 Apr 2021
US 2024/0197701 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results